Literature DB >> 2863252

Pharmacological treatment of self-injurious behavior in mentally retarded persons.

N N Singh, C J Millichamp.   

Abstract

Self-injury is a severe behavioral problem commonly observed in institutionalized mentally retarded individuals. While several forms of therapy are available, pharmacological treatment is most often used in institutions to control this behavior. This paper evaluated the clinical and experimental literature on the effects of pharmacotherapy for self-injury. Few general conclusions could be drawn mainly due to the small number of studies and the general lack of methodological rigor of these studies. However, there was some indication that antipsychotics and antimanics may prove to be useful in the treatment of self-injury and warrant further investigation. Several areas of future research were discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863252     DOI: 10.1007/bf01531497

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  31 in total

1.  LONG TERM CLINICAL TRIAL WITH DIAZEPAM ON ADULT MENTALLY RETARDED PERSONS.

Authors:  M GALAMBOS
Journal:  Dis Nerv Syst       Date:  1965-05

2.  Use of tranquilizers for mentally deficient patients.

Authors:  W C ADAMSON; B P NELLIS; G RUNGE; C CLELAND; E KILLIAN
Journal:  AMA J Dis Child       Date:  1958-08

3.  An applied dose-response curve of thioridazine with the mentally retarded: aggressive, self-stimulatory, intellectual, and workshop behaviors--a preliminary report.

Authors:  S E Breuning
Journal:  Psychopharmacol Bull       Date:  1982-01

4.  A behavioral/pharmacological intervention for the treatment of severe self-injurious behavior.

Authors:  V M Durand
Journal:  J Autism Dev Disord       Date:  1982-09

5.  The effect of L-5-hydroxytryptophan on self-mutilatin in Lesch-Nyhan disease: a negative report.

Authors:  L T Anderson; L Herrmann; J Dancis
Journal:  Neuropadiatrie       Date:  1976-11

6.  The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.

Authors:  R D Ciaranello; T F Anders; J D Barchas; P A Berger; H M Cann
Journal:  Child Psychiatry Hum Dev       Date:  1976

7.  A retrospective evaluation of pipamperone (Dipiperon) in the treatment of behavioural deviations in severely mentally handicapped.

Authors:  J Haegeman; F Duyck
Journal:  Acta Psychiatr Belg       Date:  1978 Mar-Apr

8.  Naloxone attenuates self-abusive behavior in developmentally disabled clients.

Authors:  C A Sandman; P C Datta; J Barron; F K Hoehler; C Williams; J M Swanson
Journal:  Appl Res Ment Retard       Date:  1983

9.  The management of chronic behavior disorders in mentally retarded adults with lithium carbonate.

Authors:  R Sovner; A Hurley
Journal:  J Nerv Ment Dis       Date:  1981-03       Impact factor: 2.254

10.  Effects of thioridazine dosage on the behavior of severely mentally retarded persons.

Authors:  N N Singh; M G Aman
Journal:  Am J Ment Defic       Date:  1981-05
View more
  7 in total

Review 1.  Typical neuroleptics in child and adolescent psychiatry.

Authors:  C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Functional communication training to reduce challenging behavior: maintenance and application in new settings.

Authors:  V M Durand; E G Carr
Journal:  J Appl Behav Anal       Date:  1991

3.  Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.

Authors:  S R Schroeder; J Rojahn; R M Reese
Journal:  J Autism Dev Disord       Date:  1997-02

4.  The effect of clozapine on self-injurious behavior.

Authors:  R G Hammock; S R Schroeder; W R Levine
Journal:  J Autism Dev Disord       Date:  1995-12

5.  Treatment abuse and its reduction.

Authors:  E Schopler
Journal:  J Autism Dev Disord       Date:  1986-06

6.  Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.

Authors:  J A Yaryura-Tobias; M S Grunes; M E Bayles; F Neziroglu
Journal:  Eat Weight Disord       Date:  1998-12       Impact factor: 4.652

7.  A case report of naltrexone treatment of self-injury and social withdrawal in autism.

Authors:  A S Walters; R P Barrett; C Feinstein; A Mercurio; W T Hole
Journal:  J Autism Dev Disord       Date:  1990-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.